Global Continuous Renal Replacement Therapy (CRRT) Market is Poised to grow at a rate of ~7-9% by 2027


Growing prevalence of acute kidney injury (AKI), the rising geriatric population, the growing occurrence of sepsis, and the growing clinical advantage of continuous renal replacement therapy over intermittent blood purification are some of the crucial factors driving the global continuous renal replacement therapy (CRRT) market.

CRRT is a slow and gentle method of dialysis that removes excess fluids and waste products from the blood in a continuous basis, much like the kidneys function in healthy individuals.

Adoption of CRRT for the Treatment of Critically ill Patients with Acute Kidney Injury (AKI) Drives Demand in Continuous Renal Replacement Therapy (CRRT) Market

Acute Kidney Injury (AKI) is a global problem and is common amongst critically ill patients. It is estimated that 13.3 million people globally are affected by AKI every year, ~85% of which live in developing nations. The goals of CRRT for critically ill patients with AKI include maintaining fluid, electrolyte, acid-base, and solute balance, supporting renal recovery, and allowing other supportive interventions to proceed without complication or limitation.           

Advantages Associated with CRRT Drives the Continuous Renal Replacement Therapy (CRRT) Market Growth

Critically ill patients with AKI undergoing Renal Replacement Therapy (RRT) often experience frequent episodes of hemodynamic instability. CRRT may have a better hemodynamic profile compared with other intermittent therapies, including intermittent hemodialysis (IHD) and sustained low-efficiency dialysis. Among the CRRT’s advantages, compared to other RRT, is preventing changes in intracerebral water. CRRT is also considered safer than IHD in patients at risk of cerebral edema.

Increasing Awareness Regarding Kidney Health & Prevention Program Drives the Continuous Renal Replacement Therapy (CRRT) Market

Presently, a large number of kidney health & prevention programs are run by organizations such as National Kidney Foundation (NKF), The National Kidney Disease Education Program (NKDEP), and local governments worldwide to raise awareness regarding evidence-based interventions to improve understanding, detection, and management of kidney disease. For instance,

§  In September 2022, Fresenius Medical Care, announced they have signed a memorandum of understanding (MoU) with the National Kidney Foundation
(NKF) Malaysia, this collaboration is to join efforts in raising awareness about kidney health and the prevention of chronic kidney disease amongst children and their families in Malaysia

 

Covid-19 Impact on the Continuous Renal Replacement Therapy (CRRT) Market

The global healthcare systems have faced significant challenges due to the COVID-19 pandemic. Among the patients hospitalized with COVID-19, a considerable proportion, ranging from 15% to 30%, exhibited signs of kidney failure and required Continuous Renal Replacement Therapy (CRRT). In these instances, CRRT acted as a life-sustaining and life-saving therapy.

Key Constraints of the Continuous Renal Replacement Therapy (CRRT) Market  

The high cost of the CRRT procedures and the risk & complications associated with the CRRT such as catheter-related complications, blood loss, infection or access failure, fluctuations in salt balance, hemodialysis-related complications, coagulopathy, and venous thrombosis are likely to hinder the growth of the continuous renal replacement therapy market in the coming years.

North America Expected to Continue to Hold a large Share in the Continuous Renal Replacement Therapy (CRRT) Market

From a geographical outlook, North America holds a major market share of the continuous renal replacement therapy market. This can be primarily attributed to the growing incidences of AKI, technological advancements in continuous renal replacement therapy products, and an increase in the number of diabetic patients in North America.

Competitive Landscape Analysis of the Continuous Renal Replacement Therapy (CRRT) Market

Some of the key companies operating in the market include Baxter, B. Braun, Fresenius Medical Care AG, Medtronic, and Nipro Corporation, among others.

Organic and Inorganic Growth Strategies Adopted by Players to Establish Their Foothold in the Market

Companies operating in this market are adopting organic and inorganic growth strategies such as collaborations, acquisitions, and new product launches to garner market share. Such as,

§  In August 2022, Fresenius Medical Care closed a three-way merger including Fresenius Health Partners, the value-based care division of Fresenius Medical Care North America, and created a premier value-based kidney care provider in the U.S

 

§  In April 2022, Baxter International Inc. announced the U.S. FDA 510(k) clearance of the company’s ST Set used in continuous renal replacement therapy (CRRT)


Get Detailed Insights on the Continuous Renal Replacement Therapy (CRRT) Market @ https://meditechinsights.com/continuous-renal-replacement-therapy-market/

 

Comments

Post a Comment

Popular posts from this blog

The Transplantation Market Anticipated to Expand with 9-10% CAGR by 2029 as Need for Organ Transplants Rises

Image
  The market is propelled by various factors, including advancements in medical technology, the rising prevalence of chronic diseases that lead to organ failure, increasing awareness of transplantation as a viable treatment option, and evolving regulatory and reimbursement policies. In medical terms, transplantation refers to the surgical procedure of transferring cells, tissues, or organs from a donor to a recipient to replace malfunctioning or damaged body parts. Its primary goal is to restore normal function or improve the quality of life for the recipient. Transplantation is often used to treat end-stage organ failure, severe injuries, certain cancers, and congenital defects that are not manageable through other medical treatments. This specialized field requires careful matching of donors and recipients, advanced surgical techniques, and comprehensive post-transplant care to ensure success. Types of transplantation include: Kidney Transplantation: Involves replacing a fail...
Read more

Global 3D Cell Culture Market Seeks Prosperous Horizon: Double-Digit Growth Expected by 2027

Image
  The need for organ transplants and tissue engineering combined with developments in scaffold-free technology, a rise in investments and research and development (R&D) funding for cell-based studies, growing efforts to develop potential alternatives to animal-based testing, and the rising incidence of chronic diseases are some of the major factors propelling the growth of the global 3D cell culture market. 3D cell culture   is an important approach in cell biology and tissue engineering because it includes cultivating and analyzing cells in a three-dimensional environment that mimics the circumstances present in the human body. It has several advantages, such as the capacity to recreate in vivo settings, allow the creation of complex multicellular structures, and give realistic drug testing situations. Scaffold-based technologies employing materials such as hydrogels are employed for 3D cell culturing. Its uses include cancer research, tissue engineering, and medication d...
Read more

Global Tricuspid Valve Repair Market Driven by Innovation: Set to Surge with a US$2.5 Billion Market by 2028

Image
  Increasing geriatric population, growing preference for minimally invasive procedures like annuloplasty and transcatheter tricuspid valve repair (TTVR), increased clinical research and trials activities for developing new tricuspid valve repair technologies, and rising incidence of tricuspid valve disorders are some of the key factors driving the global tricuspid valve repair market. • Medical technology advancements in the field of cardiac interventions. • Improved awareness of heart valve disorders. One of the four valves in our heart that regulates blood flow is the tricuspid valve . It is located between the ventricle and the atrium, the upper and lower chambers of our heart, on the right side. It guarantees that blood travels from the right atrium to the right ventricle in the proper path. As blood passes through the tricuspid valve, its three leaflets, or flaps, open and close. Tricuspid valve illnesses are disorders that some people have that impair the tricuspid valve's a...
Read more